Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
Barrett BJ, Carlisle EJ. Barrett BJ, et al. Radiology. 1993 Jul;188(1):171-8. doi: 10.1148/radiology.188.1.8511292. Radiology. 1993. PMID: 8511292
Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Owen RJ, et al. Among authors: barrett bj. Can Assoc Radiol J. 2014 May;65(2):96-105. doi: 10.1016/j.carj.2012.11.002. Epub 2014 Feb 20. Can Assoc Radiol J. 2014. PMID: 24559602
Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Barrett BJ, et al. Invest Radiol. 2006 Nov;41(11):815-21. doi: 10.1097/01.rli.0000242807.01818.24. Invest Radiol. 2006. PMID: 17035872 Clinical Trial.
Risk of iodinated contrast material--induced nephropathy with intravenous administration.
Katzberg RW, Barrett BJ. Katzberg RW, et al. Among authors: barrett bj. Radiology. 2007 Jun;243(3):622-8. doi: 10.1148/radiol.2433061411. Epub 2007 Apr 19. Radiology. 2007. PMID: 17446526 Review. No abstract available.
Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis.
Howse PM, Chibrikova LN, Twells LK, Barrett BJ, Gamble JM. Howse PM, et al. Among authors: barrett bj. Am J Kidney Dis. 2016 Nov;68(5):733-742. doi: 10.1053/j.ajkd.2016.06.014. Epub 2016 Aug 12. Am J Kidney Dis. 2016. PMID: 27528374 Review.
Clinical practice. Preventing nephropathy induced by contrast medium.
Barrett BJ, Parfrey PS. Barrett BJ, et al. N Engl J Med. 2006 Jan 26;354(4):379-86. doi: 10.1056/NEJMcp050801. N Engl J Med. 2006. PMID: 16436769 Review. No abstract available.
Contrast nephrotoxicity.
Barrett BJ. Barrett BJ. J Am Soc Nephrol. 1994 Aug;5(2):125-37. J Am Soc Nephrol. 1994. PMID: 7993992 Review.
Safety and criteria for selective use of low-osmolality contrast for cardiac angiography.
Barrett BJ, Parfrey PS, Morton BC. Barrett BJ, et al. Med Care. 1998 Aug;36(8):1189-97. doi: 10.1097/00005650-199808000-00007. Med Care. 1998. PMID: 9708591
An economic analysis of strategies for the use of contrast media for diagnostic cardiac catheterization.
Barrett BJ, Parfrey PS, Foley RN, Detsky AS. Barrett BJ, et al. Med Decis Making. 1994 Oct-Dec;14(4):325-35. doi: 10.1177/0272989X9401400403. Med Decis Making. 1994. PMID: 7808208
A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. Barrett BJ, et al. N Engl J Med. 1992 Feb 13;326(7):431-6. doi: 10.1056/NEJM199202133260702. N Engl J Med. 1992. PMID: 1732770 Clinical Trial.
102 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page